Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 935M | 932M | 943M | 911M | 983M | 1.04B |
| Cost of revenue | 649M | 673M | 657M | 639M | 701M | 724M |
| Research and development | 32M | 33M | 33M | 37M | 43M | 45M |
| Selling, general and administrative | 93M | 86M | 88M | 86M | 102M | 93M |
| Operating expenses | 793M | 1.05B | 805M | 789M | 1.18B | 906M |
| Operating income | 142M | −123M | 138M | 122M | −199M | 130M |
| Pre-tax income | 116M | −148M | 106M | 91M | −245M | 99M |
| Income tax | 28M | 14M | 45M | 21M | −220M | 27M |
| Net income | 87M | −163M | 61M | 70M | −25M | 72M |
| Earnings per share | 0.60 | −1.12 | 0.41 | 0.47 | −0.17 | 0.48 |
| Earnings per share, diluted | 0.59 | −1.12 | 0.41 | 0.47 | −0.17 | 0.47 |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 635M | 573M | 791M | 662M | 588M | 594M | 506M | 1.03B |
| Receivables | 693M | 657M | 725M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 123M | — | — | 119M | — | — |
| Depreciation and amortisation | 34M | — | — | 41M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 785M |
| 695M |
| 660M |
| 754M |
| 809M |
| Inventory | 606M | 618M | 641M | 636M | 661M | 615M | 674M | 708M |
| Current assets | 2.09B | 1.99B | 2.31B | 2.24B | 2.10B | 2.03B | 2.10B | 2.70B |
| Goodwill | 3.16B | 3.16B | 3.16B | 3.38B | 3.38B | 3.38B | 3.39B | 3.54B |
| Total assets | 6.82B | 6.75B | 7.07B | 7.27B | 7.18B | 7.14B | 7.31B | 8.19B |
| Current liabilities | 759M | 775M | 794M | 827M | 794M | 711M | 807M | 1.52B |
| Long-term debt | 2.83B | 2.83B | 3.18B | 3.18B | 3.18B | 3.18B | 3.17B | 3.17B |
| Total liabilities | 3.96B | 3.97B | 4.35B | 4.39B | 4.33B | 4.25B | 4.36B | 5.18B |
| Equity | 2.86B | 2.79B | 2.72B | 2.88B | 2.85B | 2.89B | 2.96B | 3.01B |
| Shares outstanding | — | 177M | 177M | 177M | 177M | 177M | 176M | 176M |
| Shares issued | — | 177M | 177M | 177M | 177M | 177M | 176M | 176M |
| Treasury shares | 32M | 31M | 31M | 31M | 31M | 27M | 26M | 25M |
| — |
| — |
| Share-based compensation | 7M | — | — | 7M | — | — |
| Capital expenditure | 18M | — | — | 33M | — | — |
| Investing cash flow | −17M | — | — | −7M | — | — |
| Dividends paid | 18M | 18M | 18M | 18M | 18M | 18M |
| Share buybacks | 25M | — | — | 101M | — | — |
| Financing cash flow | −45M | — | — | −119M | — | — |